| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |